BIOMAT Database Logo BIOMAT Database Logo

Insulin and non-suppressible insulin-like activity (NSILA-s): evidence for separate plasma membrane receptor sites. 1974

K Megyesi, and C R Kahn, and J Roth, and E R Froesch, and R E Humbel, and J Zapf, and D M Neville

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007330 Insulin Antibodies Antibodies specific to INSULIN. Antibodies, Insulin
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D011384 Proinsulin A pancreatic polypeptide of about 110 amino acids, depending on the species, that is the precursor of insulin. Proinsulin, produced by the PANCREATIC BETA CELLS, is comprised sequentially of the N-terminal B-chain, the proteolytically removable connecting C-peptide, and the C-terminal A-chain. It also contains three disulfide bonds, two between A-chain and B-chain. After cleavage at two locations, insulin and C-peptide are the secreted products. Intact proinsulin with low bioactivity also is secreted in small amounts.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011955 Receptors, Drug Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified. Drug Receptors,Drug Receptor,Receptor, Drug
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell

Related Publications

K Megyesi, and C R Kahn, and J Roth, and E R Froesch, and R E Humbel, and J Zapf, and D M Neville
[Physiological significance of NSILA (non-suppressible insulin-like activity)].
March 1969, Saishin igaku. Modern medicine,
K Megyesi, and C R Kahn, and J Roth, and E R Froesch, and R E Humbel, and J Zapf, and D M Neville
Endocrine influences on serum acid-ethanol soluble non-suppressible in insulin-like activity (NSILA-S).
February 1980, Clinical endocrinology,
K Megyesi, and C R Kahn, and J Roth, and E R Froesch, and R E Humbel, and J Zapf, and D M Neville
Binding of nonsuppressible insulin-like activity (NSILA) to isolated fat cells: evidence for two separate membrane acceptor sites.
August 1976, FEBS letters,
K Megyesi, and C R Kahn, and J Roth, and E R Froesch, and R E Humbel, and J Zapf, and D M Neville
Growth-hormone dependence of non-suppressible insulin-like activity (NSILA) and of NSILA-carrier protein in rats.
April 1978, Acta endocrinologica,
K Megyesi, and C R Kahn, and J Roth, and E R Froesch, and R E Humbel, and J Zapf, and D M Neville
Evidence for a biologically active, carrier-bound form of non-suppressible insulin-like activity (NSILA) in human serum.
January 1983, The International journal of biochemistry,
K Megyesi, and C R Kahn, and J Roth, and E R Froesch, and R E Humbel, and J Zapf, and D M Neville
Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum.
January 1985, The International journal of biochemistry,
K Megyesi, and C R Kahn, and J Roth, and E R Froesch, and R E Humbel, and J Zapf, and D M Neville
Stimulation of ornithine decarboxylase activity in chick fibroblasts by non-suppressible insulin-like activity (NSILA), insulin and serum.
June 1976, Journal of cellular physiology,
K Megyesi, and C R Kahn, and J Roth, and E R Froesch, and R E Humbel, and J Zapf, and D M Neville
Non-suppressible insulin-like activity of human serum. II. Biological properties of plasma extracts with non-suppressible insulin-like activity.
June 1966, Biochimica et biophysica acta,
K Megyesi, and C R Kahn, and J Roth, and E R Froesch, and R E Humbel, and J Zapf, and D M Neville
Radioimmunoassay for non-suppressible insulin-like activity.
January 1976, Hormone research,
K Megyesi, and C R Kahn, and J Roth, and E R Froesch, and R E Humbel, and J Zapf, and D M Neville
[New studies on the nature of the non-suppressible insulin-like activity (NSILA) of human serum].
March 1970, Schweizerische medizinische Wochenschrift,
Copied contents to your clipboard!